SelSym Biotech

SelSym Biotech Develops Novel Therapies to Control Bleeding in Trauma and Surgery. The company provides Hemostatic Healing Hydrogel (H3), enabling healthcare providers to address the current severe shortage of platelet supply and shelf-life limitations, revolutionizing bleeding control in emergency and surgical settings.